CRISPR Therapeutics AG (CRSP) stock forecast for 2022 – 2027

Are you interested in CRISPR Therapeutics AG stocks prediction? If yes, then on this page you will find useful information about the dynamics of the CRSP stock price in 2022-2027. Is CRSP a good long term stock? When should I take profit in CRISPR Therapeutics AG stock? Buy or sell stock? Will CRSP stock price go up? What are analysts’ forecasts for CRSP stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. CRSP stock returns are also predicted based on historical data.

According to our research, CRSP stock is a bad long-term investment. CRSP share price has been in a bear cycle for the past year. CRISPR Therapeutics AG stock trend is negative.

CRISPR Therapeutics AG company info

Industry Biotechnology
Address Baarerstrasse 14, Zug, 6300, Switzerland
Website https://www.crisprtx.com

Forecasting

52 Week High: 71.3504 USD
52 Week Low: 49.278 USD
1 Year Forecast: 61.1344 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 4.88B
52 Week Change: -105.92%
52 Week High: 175.44 USD
52 Week Low: 55.35 USD
Beta: 1.36264
50 Day Moving Average: 71.4
90 Day Moving Average: 76.404
200 Day Moving Average: 98.49
Resistance Level: 68.4247
Pivot Point: 62.6046
Support Level: 59.913
Enterprise Value: 3,333,615,104
Forward P/E: -8.38
Forward EPS: -7.04
Profit Margin: 45.64%
Shares Outstanding: 76,527,000
EBITDA: 7.83
Held Percent Institutions: 54.44%
PEG Ratio (5Y): -0.07
Trailing EPS: 5.26

CRISPR Therapeutics AG stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

CRISPR Therapeutics AG Stock Forecast for 2022

March 2022 61 52.92 -13.25%
April 2022 52.47 56.56 7.79%
May 2022 56.56 58.8 3.96%
June 2022 60 68 13.33%
July 2022 68 60.39 -11.19%
August 2022 59.78 59 -1.3%
September 2022 59 51.51 -12.69%
October 2022 49 49 0%
November 2022 50.5 56 10.89%
December 2022 57.57 57.42 -0.26%

CRISPR Therapeutics AG Stock Forecast for 2023

January 2023 59 60.76 2.98%
February 2023 61.38 59.4 -3.23%
March 2023 60.18 51.48 -14.46%
April 2023 52 56.1 7.88%
May 2023 55.55 57.42 3.37%
June 2023 59.16 66 11.56%
July 2023 68.68 59 -14.09%
August 2023 60.6 58 -4.29%
September 2023 56.43 49.98 -11.43%
October 2023 48.02 49.98 4.08%
November 2023 49 56.1 14.49%
December 2023 54.45 57.57 5.73%

CRISPR Therapeutics AG Stock Forecast for 2024

January 2024 58.14 61.2 5.26%
February 2024 60 56.84 -5.27%
March 2024 58 50.49 -12.95%
April 2024 49.98 54 8.04%
May 2024 54 56.43 4.5%
June 2024 54.88 64.64 17.78%
July 2024 66 60.18 -8.82%
August 2024 57.82 56.56 -2.18%
September 2024 56 49.98 -10.75%
October 2024 49 46.06 -6%
November 2024 47.94 51.94 8.34%
December 2024 54.54 57.57 5.56%

CRISPR Therapeutics AG Stock Forecast for 2025

January 2025 56.43 58.41 3.51%
February 2025 58.41 56.56 -3.17%
March 2025 56.56 49.49 -12.5%
April 2025 49.5 53 7.07%
May 2025 50.96 55.55 9.01%
June 2025 53.9 64 18.74%
July 2025 63.7 57 -10.52%
August 2025 57.57 54.45 -5.42%
September 2025 53.9 47.04 -12.73%
October 2025 46.06 45.9 -0.35%
November 2025 44.1 51.48 16.73%
December 2025 53.04 55.55 4.73%

CRISPR Therapeutics AG Stock Forecast for 2026

January 2026 55 55.86 1.56%
February 2026 57.42 53.9 -6.13%
March 2026 53.9 48.02 -10.91%
April 2026 48.02 52.02 8.33%
May 2026 52.02 54.54 4.84%
June 2026 52.92 64.26 21.43%
July 2026 63.36 55.55 -12.33%
August 2026 54.88 55.08 0.36%
September 2026 52.92 47.47 -10.3%
October 2026 45.54 43.12 -5.31%
November 2026 44.44 49.98 12.47%
December 2026 53.04 54.54 2.83%

CRISPR Therapeutics AG Stock Forecast for 2027

January 2027 53.46 56.56 5.8%